Amgen — May 1, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000318154-25-000018
Showing in the filing
Non-GAAP tax rate
“14.5 % — 16.0 %”
Period
FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 8
Dividend for Q1 FY2025
“$2.38”
Total revenues for FY2025
“$34.3 billion to $35.7 billion”
Capital expenditures for FY2025
“approximately $2.3 billion”
Share repurchases for FY2025
“not to exceed $500 million”
GAAP diluted EPS for FY2025
“$ 12.21 — $ 13.46”
Non-GAAP diluted EPS for FY2025
“$ 20.00 — $ 21.20”
GAAP tax rate for FY2025
“11.0 % — 12.5 %”
Non-GAAP tax rate for FY2025
“14.5 % — 16.0 %”
Exhibit 99.1 · the passage around this item
… earlier in the release
Reconciliation of GAAP Tax Rate Guidance to Non-GAAP Tax Rate Guidance for the Year Ending December 31, 2025 (Unaudited) GAAP tax rate guidance 11.0 % — 12.5 % Tax rate of known adjustments discussed above 3.5 % Non-GAAP tax rate guidance 14.5 % — 16.0 %
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.